Wade D P, Knight B L, Soutar A K
Medical Research Council Lipoprotein Team, Hammersmith Hospital, London, England.
Eur J Biochem. 1988 May 16;174(1):213-8. doi: 10.1111/j.1432-1033.1988.tb14084.x.
Low-density lipoprotein (LDL) receptors of approximate Mr 130,000 on non-reduced gels have been identified in Hep G2 cells by immuno- and ligand-blotting of cell extracts. Measurement of LDL receptor protein by scanning ligand blots was correlated with the specific binding, uptake and degradation of 125I-labelled LDL by intact cells, confirming that this is mediated by the LDL receptor. Cells incubated in medium with serum expressed significant LDL receptor activity. This increased when cells were transferred to medium containing lipoprotein-deficient serum (LPDS) but was not maximal because a further increase occurred when compactin was included in the medium. Inclusion of 17 alpha-ethinyl estradiol or 17 beta-estradiol in the medium at concentrations up to 500 ng/ml had no effect on LDL receptor activity in the cells as assayed by ligand blotting. Inclusion of insulin (100 mU/ml) in the preincubation medium containing LPDS resulted in a twofold increase in LDL-receptor protein and of LDL binding and degradation by intact cells. Insulin also diminished the suppressive effect of LDL on LDL receptor activity. If insulin exerts this effect in vivo it may partly explain why the liver expresses LDL receptors despite high levels of LDL in plasma and interstitial fluid.
通过对细胞提取物进行免疫印迹和配体印迹,在Hep G2细胞中鉴定出了非还原凝胶上分子量约为130,000的低密度脂蛋白(LDL)受体。通过扫描配体印迹法测定LDL受体蛋白,并与完整细胞对125I标记的LDL的特异性结合、摄取和降解相关联,证实这是由LDL受体介导的。在含血清的培养基中培养的细胞表现出显著的LDL受体活性。当细胞转移至含脂蛋白缺乏血清(LPDS)的培养基中时,该活性增加,但未达到最大值,因为当培养基中加入洛伐他汀时活性进一步增加。在培养基中加入浓度高达500 ng/ml的17α-乙炔雌二醇或17β-雌二醇,通过配体印迹法检测,对细胞中的LDL受体活性没有影响。在含有LPDS的预孵育培养基中加入胰岛素(100 mU/ml),可使LDL受体蛋白增加两倍,完整细胞对LDL的结合和降解也增加。胰岛素还减弱了LDL对LDL受体活性的抑制作用。如果胰岛素在体内发挥这种作用,这可能部分解释了为什么尽管血浆和组织液中LDL水平很高,肝脏仍表达LDL受体。